EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing

Andrew P Worth iD, Elisabet Berggren iD

Toxicological Sciences · 01.02.2025 · 203 (2) · 160-165

DOI: 10.1093/toxsci/kfae130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 03.10.2024. Verfasst von Andrew P Worth und 1 weiteren Autor:innen. Beteiligte Einrichtung: European Commission, Joint Research Centre (JRC), Ispra, Italy. Hauptthemen laut MEDLINE: Animal Testing Alternatives, Toxicity Tests, Toxicology. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission's Joint Research Centre, European Commission’s Joint Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The European regulatory framework on chemicals is at a crossroads. There are calls for the framework to be more effective, by better protecting people and the environment. There is also room for it to be more efficient and cost-effective, by harmonizing assessment practices across sectors and avoiding the need for unnecessary testing. At the same time, there is a political commitment to phase out animal testing in chemical safety assessments. In this commentary, we argue that these needs are not at odds with each other. On the contrary, the European Commission’s roadmap to phase out animal testing could also be the transition pathway to a more efficient, effective, and sustainable regulatory ecosystem. Central to our proposal is a framework based on biological reasoning in which biological questions can be answered by a choice of methods, with non-animal methods progressively becoming the only choice. Within this framework, a tiered approach to testing and assessment allows for greater efficiency and effectiveness, while also introducing considerations of proportionality and cost-effectiveness. Testing strategies, and their component methods, should be developed in tandem and judged in terms of their outcomes, and the protection levels they inform, rather than their ability to predict the outputs of animal tests.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Animal Testing AlternativesToxicity TestsToxicologyAnimalsHumansRisk AssessmentEuropean Union

Stichwörter der Autor:innen

animal testingchemical safety assessmentchemicals policynon-animal methodsrisk managementroadmap

Autor:innen und Institutionen

  • European Commission, Joint Research Centre (JRC), Ispra, Italy.

ORCID-Profile: Andrew P Worth, Elisabet Berggren

Förderung

  • European Commission's Joint Research Centre
  • European Commission’s Joint Research Centre

Zitieren

APA

Worth, A. P., & Berggren, E. (2025). A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing. Toxicological Sciences, 203(2), 160-165. https://doi.org/10.1093/toxsci/kfae130

Vancouver

Worth AP, Berggren E. A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing. Toxicological Sciences. 2025;203(2):160-165. doi:10.1093/toxsci/kfae130

BibTeX
@article{Worth2025,
  author = {Worth, Andrew P and Berggren, Elisabet},
  title = {A twin transition in regulatory toxicology: moving toward Chemicals 2.0 and phasing out animal testing},
  journal = {Toxicological Sciences},
  year = {2025},
  volume = {203},
  number = {2},
  pages = {160--165},
  doi = {10.1093/toxsci/kfae130}
}
Kostenlos starten →